Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout
Clinical trial NCT06186219 · COMPLETED
Trial details
- NCT number
- NCT06186219
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2024-11-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.